FI860251A0 - Foerfarande foer framstaellning av glukagon eller derivat daerav i en transformerad jaeststam. - Google Patents

Foerfarande foer framstaellning av glukagon eller derivat daerav i en transformerad jaeststam.

Info

Publication number
FI860251A0
FI860251A0 FI860251A FI860251A FI860251A0 FI 860251 A0 FI860251 A0 FI 860251A0 FI 860251 A FI860251 A FI 860251A FI 860251 A FI860251 A FI 860251A FI 860251 A0 FI860251 A0 FI 860251A0
Authority
FI
Finland
Prior art keywords
transformerad
jaeststam
glukagon
daerav
derivat
Prior art date
Application number
FI860251A
Other languages
English (en)
Other versions
FI87800C (fi
FI860251A (fi
FI87800B (fi
Inventor
Kjeld Norris
Lars Thim
Fanny Norris
Mogens Trier Hansen
Alister James Moody
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of FI860251A0 publication Critical patent/FI860251A0/fi
Publication of FI860251A publication Critical patent/FI860251A/fi
Application granted granted Critical
Publication of FI87800B publication Critical patent/FI87800B/fi
Publication of FI87800C publication Critical patent/FI87800C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI860251A 1985-01-22 1986-01-20 Foerfarande foer framstaellning av glukagon i jaest FI87800C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK27885A DK27885A (da) 1985-01-22 1985-01-22 Fremstilling af peptider
DK27885 1985-01-22

Publications (4)

Publication Number Publication Date
FI860251A0 true FI860251A0 (fi) 1986-01-20
FI860251A FI860251A (fi) 1986-07-23
FI87800B FI87800B (fi) 1992-11-13
FI87800C FI87800C (fi) 1993-02-25

Family

ID=8091749

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860251A FI87800C (fi) 1985-01-22 1986-01-20 Foerfarande foer framstaellning av glukagon i jaest

Country Status (17)

Country Link
US (1) US4826763A (fi)
EP (1) EP0189998B1 (fi)
JP (2) JPH0720435B2 (fi)
AT (1) ATE48643T1 (fi)
AU (1) AU587218B2 (fi)
CA (1) CA1294232C (fi)
DE (1) DE3667488D1 (fi)
DK (1) DK27885A (fi)
ES (1) ES8708250A1 (fi)
FI (1) FI87800C (fi)
GR (1) GR860149B (fi)
IE (1) IE58726B1 (fi)
MX (1) MX163776B (fi)
NO (1) NO172185C (fi)
NZ (1) NZ214883A (fi)
PT (1) PT81872B (fi)
ZA (1) ZA86393B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151354A (en) * 1986-08-21 1992-09-29 Cornelius Hollenberg Fermentation processes using amylolytic enzyme producing microorganisms
ATE121776T1 (de) * 1986-09-19 1995-05-15 Zymogenetics Inc Expression des biologisch aktiven faktors xiii.
JPH01187499A (ja) * 1988-01-21 1989-07-26 Science & Tech Agency 原子炉解体用ロボット
ZA90533B (en) * 1989-02-01 1990-10-31 Shionogi & Co A method for the production of glucagon
US6172039B1 (en) 1990-04-16 2001-01-09 Apex Bioscience, Inc. Expression of recombinant hemoglobin and hemoglobin variants in yeast
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
US5510459A (en) * 1991-01-17 1996-04-23 Zymogenetics, Inc. Glucagon antagonists
US5408037A (en) * 1991-01-17 1995-04-18 Zymogenetics, Inc. Methods for detecting glucagon antagonists
WO1994001215A1 (en) * 1992-07-06 1994-01-20 Beckman Instruments, Inc. Fluid delivery system utilizing multiple port valve
DK144093D0 (fi) * 1993-12-23 1993-12-23 Novo Nordisk As
US5652216A (en) * 1994-05-26 1997-07-29 Novo Nordisk A/S Pharmaceutical preparation
PT981362E (pt) * 1997-05-16 2004-03-31 Ontario Inc 1149336 Metodos de melhoramento do funcionamento do tracto gastrointestinal superior
WO2004060387A1 (en) * 2002-12-27 2004-07-22 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
ES2610356T3 (es) 2009-02-03 2017-04-27 Amunix Operating Inc. Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
PT2440228T (pt) 2009-06-08 2018-12-24 Amunix Operating Inc Polipéptidos de regulação da glicose e métodos de preparação e utilização dos mesmos
CN107496932A (zh) 2012-02-27 2017-12-22 阿穆尼克斯运营公司 Xten缀合组合物和制造其的方法
CN112912390B (zh) 2018-10-09 2023-12-15 北京费森尤斯卡比医药有限公司 Glp-1类似物的制备方法
EP3986919A1 (en) 2019-06-18 2022-04-27 Fresenius Kabi iPSUM S.r.l. Process for the manufacture of glucagon
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
US20230287040A1 (en) 2019-11-13 2023-09-14 Amunix Pharmaceuticals, Inc. Barcoded xten polypeptides and compositions thereof, and methods for making and using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401759A (en) * 1980-05-01 1983-08-30 Harvey Rubin Detection and isolation of glucagon mRNA using a synthetic oligodeoxynucleotide
DK283180A (da) * 1980-07-01 1982-01-02 Novo Industri As Polypeptider og derivater deraf
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins

Also Published As

Publication number Publication date
CA1294232C (en) 1992-01-14
JPH06292594A (ja) 1994-10-21
ATE48643T1 (de) 1989-12-15
NO172185B (no) 1993-03-08
ES8708250A1 (es) 1987-10-01
DK27885D0 (da) 1985-01-22
ZA86393B (en) 1987-03-25
NO172185C (no) 1993-06-16
JPH0720435B2 (ja) 1995-03-08
MX163776B (es) 1992-06-22
JPS61181398A (ja) 1986-08-14
PT81872B (pt) 1988-05-27
US4826763A (en) 1989-05-02
IE58726B1 (en) 1993-11-03
AU5247286A (en) 1986-07-31
IE860162L (en) 1986-07-22
DK27885A (da) 1986-07-23
DE3667488D1 (de) 1990-01-18
FI87800C (fi) 1993-02-25
FI860251A (fi) 1986-07-23
PT81872A (en) 1986-02-01
EP0189998A1 (en) 1986-08-06
NO860178L (no) 1986-07-23
GR860149B (en) 1986-05-21
NZ214883A (en) 1988-04-29
FI87800B (fi) 1992-11-13
JPH0746986B2 (ja) 1995-05-24
EP0189998B1 (en) 1989-12-13
AU587218B2 (en) 1989-08-10
ES551042A0 (es) 1987-10-01

Similar Documents

Publication Publication Date Title
FI860251A (fi) Foerfarande foer framstaellning av glukagon eller derivat daerav i en transformerad jaeststam.
AU2790292A (en) Viral recombinant vectors for expression in muscle cells
AU573768B2 (en) Hyaluronic acid from streptococci
AU553885B2 (en) Expression of exogenous polypeptides in yeast
AU3868889A (en) Tandem hollow fiber cell culture product harvest system
EP0318296A3 (en) Interleukin-1 receptors
HU9201712D0 (en) A mammalian cytokine, il-11
AU6733487A (en) Mammalian interleukin-4
AU682140B2 (en) Multidrug resistance gene
IE840258L (en) Expression of gene products.
BR8203507A (pt) Polipeptideo sequencia de dna veiculo de expressao microbiana replicavel plasmideo microorganismo cultura microbiana uso de um polipeptideo vacina e processo para producao de um polipeptideo
EP0314415A3 (en) Interleukin-7
EP0291728A3 (en) Production of immune interferon and its mrna
IL91888A0 (en) Improvements in or relating to eukaryotic expression
EP0276778A3 (en) High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
AU2209988A (en) Method for increasing the expression of polypeptides in recombinant cell culture
AU7265087A (en) Animal cell transformant, method for obtaining the transformant and method for producing desired foreign gene product by using the transformant
EP0343388A3 (en) Expression of interferon-gamma in methylotrophic yeasts
DK28386A (da) Fremstilling af peptider
AU2278392A (en) Method for producing recombinant proteins and host cells used therein

Legal Events

Date Code Title Description
FG Patent granted

Owner name: NOVO NORDISK A/S

MA Patent expired